drugset / Trial / NCT04885764

Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University

NCT04885764 ↗

Phase 2/3 Unknown 4000 enrolled Ain Shams University
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This is a prospective intervention study to assess the effectiveness of both the live attenuated and messenger RNA vaccines against SARS-CoV-2 infection

Timeline

Start
2021-02-23
Primary completion
2021-10-01
Completion
2021-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Astrazeneca/Oxford Vaccine Vaccine — Intramuscular
Subject Sinopharm vaccine Vaccine — Intramuscular

Indications